QXO Inc (NYSE:QXO) has a beta value of 2.32 and has seen 1.28 million shares traded in the recent trading session. The company, currently valued at $7.63B, closed the recent trade at $14.71 per share which meant it gained $0.26 on the day or 1.81% during that session. The QXO stock price is -1871.45% off its 52-week high price of $290.00 and 27.87% above the 52-week low of $10.61.
QXO Inc (NYSE:QXO) trade information
Sporting 1.81% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the QXO stock price touched $14.71 or saw a rise of 0.54%. Year-to-date, QXO Inc shares have moved -7.47%, while the 5-day performance has seen it change 9.87%. Over the past 30 days, the shares of QXO Inc (NYSE:QXO) have changed 5.77%.
QXO Inc (QXO) estimates and forecasts
The company’s shares have lost -5.99% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 4,392.47%.
1 analysts offering their estimates for the company have set an average revenue estimate of 13M for the current quarter. 1 have an estimated revenue figure of 14M for the next ending quarter.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 55.18% over the past 5 years.
QXO Dividends
QXO Inc is expected to release its next earnings report in June this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
QXO Inc (NYSE:QXO)’s Major holders
The top two institutional holders are CITADEL ADVISORS LLC with over 9.3 million shares worth more than $85.09 million. As of 2024-06-30, CITADEL ADVISORS LLC held 2.5922% of shares outstanding.
The other major institutional holder is DRIEHAUS CAPITAL MANAGEMENT LLC, with the holding of over 2.24 million shares as of 2024-06-30. The firm’s total holdings are worth over $20.49 million and represent 0.6247% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Advisor Managed Portfolios-Patient Opportunity Trust and T. Rowe Price Small-Cap Stock Fund, Inc. . As of Mar 31, 2025 , the former fund manager holds about 1.25% shares in the company for having 5.6 shares of worth $84.0 million while later fund manager owns 4.82 shares of worth $72.33 million as of Dec 31, 2024 , which makes it owner of about 1.08% of company’s outstanding stock.
